We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPX
3701
DELISTED
GP Strategies Corp.
GPX
$26K ﹤0.01%
2,025
+18
+0.9% +$254
NGS icon
3702
Natural Gas Services Group
NGS
$474M
$25.9K ﹤0.01%
2,022
+25
+1% +$343
FNWB icon
3703
First Northwest Bancorp
FNWB
$107M
$25.8K ﹤0.01%
1,490
+20
+1% +$325
OXFD
3704
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$25.8K ﹤0.01%
1,551
-1,346
-46% -$18.6K
GEOS icon
3705
Geospace Technologies
GEOS
$67.9M
$25.8K ﹤0.01%
1,677
+776
+86% +$11.2K
PZN
3706
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$25.8K ﹤0.01%
2,889
+678
+31% +$5.63K
RVSB icon
3707
Riverview Bancorp
RVSB
$106M
$25.7K ﹤0.01%
3,487
+4
+0.1% +$31
ENZ
3708
DELISTED
Enzo Biochem, Inc.
ENZ
$25.7K ﹤0.01%
7,144
+41
+0.6% +$145
NOMD icon
3709
Nomad Foods
NOMD
$1.59B
$25.7K ﹤0.01%
1,252
+609
+95% +$13K
SRGA
3710
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$25.7K ﹤0.01%
300
+1
+0.3% +$107
ESSA
3711
DELISTED
ESSA Bancorp
ESSA
$25.6K ﹤0.01%
1,562
+30
+2% +$460
BFIN
3712
DELISTED
BankFinancial
BFIN
$25.6K ﹤0.01%
2,152
-52
-2% -$652
ATHX
3713
DELISTED
Athersys, Inc. Common Stock
ATHX
$25.6K ﹤0.01%
770
+249
+48% +$8.83K
STGW icon
3714
Stagwell
STGW
$2.29B
$25.5K ﹤0.01%
9,052
-1,045
-10% -$2.62K
XME icon
3715
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.52B
$25.4K ﹤0.01%
10
NOW icon
3716
PUT
ServiceNow
NOW
$129B
$25.4K ﹤0.01%
5
NBEV
3717
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$25.4K ﹤0.01%
9,195
+9,008
+4,817% +$31.8K
SGC icon
3718
Superior Group of Companies
SGC
$213M
$25.3K ﹤0.01%
1,567
+108
+7% +$1.68K
USLM icon
3719
United States Lime & Minerals
USLM
$3.42B
$25.2K ﹤0.01%
1,645
+60
+4% +$964
HTGC icon
3720
Hercules Capital
HTGC
$3.11B
$25.1K ﹤0.01%
1,878
DHX icon
3721
DHI Group
DHX
$166M
$25K ﹤0.01%
6,483
+3,984
+159% +$14.8K
UBX
3722
DELISTED
Unity Biotechnology
UBX
$24.9K ﹤0.01%
409
+130
+47% +$9.2K
STOK icon
3723
Stoke Therapeutics
STOK
$2.13B
$24.9K ﹤0.01%
+1,158
New +$32.3K
NAGE
3724
Niagen Bioscience
NAGE
$242M
$24.9K ﹤0.01%
6,322
+1,827
+41% +$7.79K
ESQ icon
3725
Esquire Financial Holdings
ESQ
$1.61B
$24.9K ﹤0.01%
1,002
+76
+8% +$1.82K

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.